Centre Testing Intl Shenzhen
Centre Testing International Group Co. Ltd. provides testing, inspection, certification, calibration, audit, training, and technical services in China and internationally. The company operates in five segments: Trade Protection, Consumer Product Testing, Industrial Testing, Life Sciences, and pharmaceuticals and Medical Services. It offers environmental protection and regulatory; in-vehicle elect… Read more
Centre Testing Intl Shenzhen (300012) - Net Assets
Latest net assets as of September 2025: CN¥7.78 Billion CNY
Based on the latest financial reports, Centre Testing Intl Shenzhen (300012) has net assets worth CN¥7.78 Billion CNY as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥9.86 Billion) and total liabilities (CN¥2.08 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥7.78 Billion |
| % of Total Assets | 78.92% |
| Annual Growth Rate | 32.03% |
| 5-Year Change | 86.8% |
| 10-Year Change | 390.62% |
| Growth Volatility | 96.63 |
Centre Testing Intl Shenzhen - Net Assets Trend (2006–2024)
This chart illustrates how Centre Testing Intl Shenzhen's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Centre Testing Intl Shenzhen (2006–2024)
The table below shows the annual net assets of Centre Testing Intl Shenzhen from 2006 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥7.16 Billion | +11.55% |
| 2023-12-31 | CN¥6.42 Billion | +13.17% |
| 2022-12-31 | CN¥5.67 Billion | +24.46% |
| 2021-12-31 | CN¥4.56 Billion | +18.89% |
| 2020-12-31 | CN¥3.83 Billion | +19.48% |
| 2019-12-31 | CN¥3.21 Billion | +15.62% |
| 2018-12-31 | CN¥2.77 Billion | +9.34% |
| 2017-12-31 | CN¥2.54 Billion | +3.14% |
| 2016-12-31 | CN¥2.46 Billion | +68.58% |
| 2015-12-31 | CN¥1.46 Billion | +12.94% |
| 2014-12-31 | CN¥1.29 Billion | +31.05% |
| 2013-12-31 | CN¥986.10 Million | +15.18% |
| 2012-12-31 | CN¥856.11 Million | +8.31% |
| 2011-12-31 | CN¥790.41 Million | +8.89% |
| 2010-12-31 | CN¥725.91 Million | +4.30% |
| 2009-12-31 | CN¥695.99 Million | +434.03% |
| 2008-12-31 | CN¥130.33 Million | +42.74% |
| 2007-12-31 | CN¥91.30 Million | +89.56% |
| 2006-12-31 | CN¥48.16 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Centre Testing Intl Shenzhen's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 29754.5% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥4.55 Billion | 65.81% |
| Common Stock | CN¥1.68 Billion | 24.34% |
| Other Comprehensive Income | CN¥472.21 Million | 6.83% |
| Other Components | CN¥208.97 Million | 3.02% |
| Total Equity | CN¥6.91 Billion | 100.00% |
Centre Testing Intl Shenzhen Competitors by Market Cap
The table below lists competitors of Centre Testing Intl Shenzhen ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Jiangxi Lianchuang Opto-electronic Science & Technology Co Ltd
SHG:600363
|
$2.76 Billion |
|
Denali Therapeutics Inc
NASDAQ:DNLI
|
$2.76 Billion |
|
First Interstate BancSystem Inc
NASDAQ:FIBK
|
$2.76 Billion |
|
HMT(Xiamen)New Technical
SHG:603306
|
$2.76 Billion |
|
Zhejiang Wanfeng Auto Wheel Co Ltd
SHE:002085
|
$2.76 Billion |
|
SGHC Limited
NYSE:SGHC
|
$2.76 Billion |
|
TOTVS S.A
SA:TOTS3
|
$2.76 Billion |
|
Hindustan Zinc Limited
NSE:HINDZINC
|
$2.75 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Centre Testing Intl Shenzhen's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 6,205,345,102 to 6,913,388,893, a change of 708,043,791 (11.4%).
- Net income of 921,073,110 contributed positively to equity growth.
- Dividend payments of 169,289,683 reduced retained earnings.
- Share repurchases of 28,551,655 reduced equity.
- Other comprehensive income increased equity by 45,162,259.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥921.07 Million | +13.32% |
| Dividends Paid | CN¥169.29 Million | -2.45% |
| Share Repurchases | CN¥28.55 Million | -0.41% |
| Other Comprehensive Income | CN¥45.16 Million | +0.65% |
| Other Changes | CN¥-60.35 Million | -0.87% |
| Total Change | CN¥- | 11.41% |
Book Value vs Market Value Analysis
This analysis compares Centre Testing Intl Shenzhen's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.67x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 346.09x to 3.67x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2006-12-31 | CN¥0.04 | CN¥15.13 | x |
| 2007-12-31 | CN¥0.08 | CN¥15.13 | x |
| 2008-12-31 | CN¥0.12 | CN¥15.13 | x |
| 2009-12-31 | CN¥0.61 | CN¥15.13 | x |
| 2010-12-31 | CN¥0.49 | CN¥15.13 | x |
| 2011-12-31 | CN¥0.53 | CN¥15.13 | x |
| 2012-12-31 | CN¥0.58 | CN¥15.13 | x |
| 2013-12-31 | CN¥0.65 | CN¥15.13 | x |
| 2014-12-31 | CN¥0.85 | CN¥15.13 | x |
| 2015-12-31 | CN¥0.95 | CN¥15.13 | x |
| 2016-12-31 | CN¥1.89 | CN¥15.13 | x |
| 2017-12-31 | CN¥1.49 | CN¥15.13 | x |
| 2018-12-31 | CN¥1.64 | CN¥15.13 | x |
| 2019-12-31 | CN¥1.89 | CN¥15.13 | x |
| 2020-12-31 | CN¥2.24 | CN¥15.13 | x |
| 2021-12-31 | CN¥2.66 | CN¥15.13 | x |
| 2022-12-31 | CN¥3.26 | CN¥15.13 | x |
| 2023-12-31 | CN¥3.73 | CN¥15.13 | x |
| 2024-12-31 | CN¥4.13 | CN¥15.13 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Centre Testing Intl Shenzhen utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 13.32%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 15.14%
- • Asset Turnover: 0.64x
- • Equity Multiplier: 1.37x
- Recent ROE (13.32%) is below the historical average (16.00%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2006 | 36.39% | 25.43% | 1.24x | 1.15x | CN¥12.71 Million |
| 2007 | 43.58% | 32.79% | 1.05x | 1.27x | CN¥30.66 Million |
| 2008 | 29.45% | 18.91% | 1.01x | 1.55x | CN¥25.35 Million |
| 2009 | 8.13% | 22.52% | 0.34x | 1.06x | CN¥-13.05 Million |
| 2010 | 9.50% | 19.31% | 0.46x | 1.07x | CN¥-3.63 Million |
| 2011 | 12.26% | 19.13% | 0.59x | 1.09x | CN¥17.66 Million |
| 2012 | 13.91% | 19.10% | 0.64x | 1.13x | CN¥33.08 Million |
| 2013 | 15.39% | 19.26% | 0.67x | 1.19x | CN¥52.44 Million |
| 2014 | 11.49% | 15.78% | 0.58x | 1.25x | CN¥18.98 Million |
| 2015 | 12.64% | 14.02% | 0.68x | 1.32x | CN¥37.72 Million |
| 2016 | 4.23% | 6.15% | 0.53x | 1.30x | CN¥-138.58 Million |
| 2017 | 5.38% | 6.32% | 0.60x | 1.41x | CN¥-115.06 Million |
| 2018 | 9.94% | 10.07% | 0.66x | 1.49x | CN¥-1.76 Million |
| 2019 | 15.14% | 14.97% | 0.72x | 1.41x | CN¥161.68 Million |
| 2020 | 15.43% | 16.19% | 0.65x | 1.46x | CN¥203.18 Million |
| 2021 | 16.74% | 17.24% | 0.67x | 1.45x | CN¥300.46 Million |
| 2022 | 16.49% | 17.59% | 0.66x | 1.42x | CN¥355.33 Million |
| 2023 | 14.67% | 16.24% | 0.64x | 1.41x | CN¥289.67 Million |
| 2024 | 13.32% | 15.14% | 0.64x | 1.37x | CN¥229.73 Million |
Industry Comparison
This section compares Centre Testing Intl Shenzhen's net assets metrics with peer companies in the Consulting Services industry.
Industry Context
- Industry: Consulting Services
- Average net assets among peers: $608,694,116
- Average return on equity (ROE) among peers: 3.02%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Centre Testing Intl Shenzhen (300012) | CN¥7.78 Billion | 36.39% | 0.27x | $2.76 Billion |
| Grg Metrology (002967) | $774.34 Million | 13.88% | 0.89x | $788.86 Million |
| Shanghai HYP-ARCH Architectural Design Consultant Co.Ltd. (301024) | $664.40 Million | -26.79% | 0.20x | $79.54 Million |
| China Building Material (603060) | $387.35 Million | 21.98% | 0.56x | $222.42 Million |